MyFinsight
Home
Blog
About
Cash and cash
equivalents
$100,156K
(-40.87%↓ Y/Y)
Prepaid expenses and
other current assets
$4,247K
(37.67%↑ Y/Y)
Total current assets
$104,403K
(-52.79%↓ Y/Y)
Right-of-use assets
$54,228K
(-11.24%↓ Y/Y)
Property and equipment,
net
$7,743K
(-18.67%↓ Y/Y)
Restricted cash
$5,031K
(0.00%↑ Y/Y)
Long-term deposit and
other assets
$47K
(-97.36%↓ Y/Y)
Total assets
$171,452K
(-42.57%↓ Y/Y)
Total liabilities and
stockholders' equity
$171,452K
(-42.57%↓ Y/Y)
Total liabilities
$102,433K
(-15.93%↓ Y/Y)
Total stockholders'
equity
$69,019K
(-60.94%↓ Y/Y)
Accumulated deficit
-$563,887K
(-26.38%↓ Y/Y)
Operating lease
liability, net of current...
$50,397K
(-13.28%↓ Y/Y)
Total current
liabilities
$30,964K
(-1.14%↓ Y/Y)
Long-term debt, net
$21,072K
(-34.75%↓ Y/Y)
Additional paid-in capital
$632,898K
(1.61%↑ Y/Y)
Common stock-Voting
Common Stock
$7K
(40.00%↑ Y/Y)
Common
stock-Nonvoting Common Stock
$1K
(0.00%↑ Y/Y)
Current portion of
long-term debt
$11,707K
Accrued expenses and
other current...
$7,832K
(-38.80%↓ Y/Y)
Operating lease
liability, current portion
$7,717K
(22.73%↑ Y/Y)
Accounts payable
$3,122K
(-31.22%↓ Y/Y)
Deferred revenue,
current portion
$586K
(-92.39%↓ Y/Y)
Back
Back
Balance Sheet
TScan Therapeutics, Inc. (TCRX)
TScan Therapeutics, Inc. (TCRX)
source: myfinsight.com